Publication | Closed Access

OnabotulinumtoxinA Improves Health-Related Quality of Life in Patients With Urinary Incontinence Due to Idiopathic Overactive Bladder: A 36-Week, Double-Blind, Placebo-Controlled, Randomized, Dose-Ranging Trial

UrologyVoiding DysfunctionHealth-related QualityFemale UrologyDose-ranging TrialUrogynecologyUrinary Incontinence DueMedicine